Can a common pain reliever hold hidden risks for unborn children? In this episode, Dr. Manfred Stapff tackles one of medicine’s most debated questions, whether acetaminophen use during pregnancy could influence autism risk.

Dr. Manfred explores the rise in autism diagnoses, explaining how shifting definitions and improved awareness shape the numbers. He then analyzes key studies, from the Boston Birth Cohort to Sweden’s national registry, revealing why research outcomes differ.

While data show mixed findings, acetaminophen remains one of the safest treatments for pain and fever in pregnancy when used responsibly. Sometimes, the greater risk lies not in the medicine itself but in what happens when we avoid it.

Tune in for a powerful conversation that moves beyond fear toward informed understanding. Uncovering the Truth: Acetaminophen Use in Pregnancy and Autism Risk.

Dr. Manfred Stapff is an entrepreneurial biotech and pharmaceutical expert with deep expertise in real-world evidence and clinical research. As a seasoned leader, he brings decades of experience across all phases of drug development, from opportunity assessment to product launch. His work bridges science and strategy, ensuring medical decisions are grounded in accurate, meaningful data. Dr. Stapff is also an author, committed to promoting evidence-based thinking in medicine. His insights challenge misinformation and advocate for scientific integrity in today’s data-driven world.

Connect with Dr. Manfred Stapff, MD:

LinkedIn: https://www.linkedin.com/in/manfredstapff/